European Investment Bank (EIB) Extends Financing Agreement to Euro24 Million Total in Support of BiondVax's Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial

Stock Information for BiondVax Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.